1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Maternal Obesity

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Maternal Obesity in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Airoldi, C; Basello, K; Cappelletti, M; Ciliberti, A; Costanzi, A; Dessì, DA; Familiari, A; Lanzone, A; Neri, C; Speciani, AF; Tersigni, C	1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Maternal Obesity

Article	Year
B-cell-activating factor (BAFF) and platelet-activating factor (PAF) in pregnancies complicated by maternal obesity and diabetes: a preliminary study. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2023, Volume: 36, Issue:2 Topics: Biomarkers; Diabetes, Gestational; Female; Humans; Inflammation; Longitudinal Studies; Obesity; Obesity, Maternal; Platelet Activating Factor; Pregnancy; Prospective Studies	2023

Article

Year

B-cell-activating factor (BAFF) and platelet-activating factor (PAF) in pregnancies complicated by maternal obesity and diabetes: a preliminary study.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2023, Volume: 36, Issue:2

Topics: Biomarkers; Diabetes, Gestational; Female; Humans; Inflammation; Longitudinal Studies; Obesity; Obesity, Maternal; Platelet Activating Factor; Pregnancy; Prospective Studies

2023